Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Haidar G, Thomas S, Loubet P, Baker RI, Benfield T, Boonyaratanakornkit J, Kiertiburanakul S, Kim AHJ, Longbrake EE, Molina JM, Paredes R, Tucker D, Uriel A, Weinmann-Menke J, Aksyuk AA, Clegg LE, Currie A, Yang H, Flyrin K, Gibbs M, Shroff M, Perez JL, Chang LJ, Cohen TS. Efficacy and safety of sipavibart for prevention of COVID-19 in individuals who are immunocompromised (SUPERNOVA): a randomised, controlled, double-blind, phase 3 trial. Lancet Infect Dis 2025:S1473-3099(24)00804-1. [PMID: 40015292 DOI: 10.1016/s1473-3099(24)00804-1] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/01/2024] [Revised: 11/20/2024] [Accepted: 11/27/2024] [Indexed: 03/01/2025]

For:	Haidar G, Thomas S, Loubet P, Baker RI, Benfield T, Boonyaratanakornkit J, Kiertiburanakul S, Kim AHJ, Longbrake EE, Molina JM, Paredes R, Tucker D, Uriel A, Weinmann-Menke J, Aksyuk AA, Clegg LE, Currie A, Yang H, Flyrin K, Gibbs M, Shroff M, Perez JL, Chang LJ, Cohen TS. Efficacy and safety of sipavibart for prevention of COVID-19 in individuals who are immunocompromised (SUPERNOVA): a randomised, controlled, double-blind, phase 3 trial. Lancet Infect Dis 2025:S1473-3099(24)00804-1. [PMID: 40015292 DOI: 10.1016/s1473-3099(24)00804-1] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/01/2024] [Revised: 11/20/2024] [Accepted: 11/27/2024] [Indexed: 03/01/2025]

Number

Cited by Other Article(s)

Gerstenberg J, Lübbert C, Widera M, Schleenvoigt BT. The need of preexposure prophylaxis against COVID-19 in immunocompromised patients- an assessment from Germany. Infection 2025:10.1007/s15010-025-02540-w. [PMID: 40261482 DOI: 10.1007/s15010-025-02540-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2025] [Accepted: 04/08/2025] [Indexed: 04/24/2025]

Focosi D, Casadevall A. Sipavibart: when a success changes into a failure. THE LANCET. INFECTIOUS DISEASES 2025:S1473-3099(24)00812-0. [PMID: 40015293 DOI: 10.1016/s1473-3099(24)00812-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/30/2024] [Accepted: 12/02/2024] [Indexed: 03/01/2025]